Professor Vincent Lawton is Chairman of Addex's Board of Directors, chairs the Audit Committee and is a member of the Compensation Committee. He was Vice President Merck Europe and Managing Director of MSD UK until he stepped down in 2006, after 26 years' service internationally for Merck & Co. He was appointed CBE for services to the pharmaceutical industry and, as President of the ABPI, helped establish the UK as a leading centre of clinical research. He served on the board of the UK regulatory authority (MHRA) from 2008 to 2015, was Senior Strategy Adviser for Imperial College Department of Medicine and is a board member of Neurosterix. He studied Psychology at the University of London, where he holds an undergraduate degree and a PhD.